Quantcast

Latest American Society of Clinical Oncology Stories

2014-05-31 08:21:17

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that data from the PROCLAIM(SM) national patient registry retrospective cohort document an improvement in median overall survival (OS) in patients with metastatic melanoma who were treated with high-dose Proleukin(®) (aldesleukin) as compared to...

2014-05-30 23:04:55

Leslie Robison, Ph.D., becomes the fifth researcher from St. Jude Children’s Research Hospital to receive the Pediatric Oncology Award Memphis, Tenn. (PRWEB) May 30, 2014 The American Society of Clinical Oncology (ASCO) has named Leslie L. Robison, Ph.D., of St. Jude Children’s Research Hospital the recipient of the 2014 Pediatric Oncology Award for his contributions to the field of childhood cancer survivorship research. Robison will receive the award Saturday at the ASCO annual...

2014-05-30 16:23:41

NEW YORK, May 30, 2014 /PRNewswire/ -- MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), announces the launch of "Video Conference Reporter," to provide recorded real-time video coverage of major oncology research presented at leading scientific sessions worldwide. http://photos.prnewswire.com/prnvar/20101112/NY00568LOGO "Our partnerships with key professional medical organizations are one of the cornerstones of MedPage Today, and what sets us apart from other news...

2014-05-30 08:25:14

Retrospective Analysis Demonstrates Survival Benefits for Patients with Stable and Progressive Disease after HD IL-2 in the Modern Era Suggesting Appropriate Drug Sequencing May Improve Outcomes CHICAGO, May 30, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that analysis of data from the PROCLAIM(SM) national patient registry retrospective cohort shows improved overall survival in metastatic RCC patients treated with high-dose Proleukin(®) (aldesleukin) in the...

2014-05-29 20:22:58

THOUSAND OAKS, Calif., May 29, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will hold a post-American Society of Clinical Oncology (ASCO) summary webcast on Tuesday, June 3, 2014, at 1 p.m. PT. Sean E. Harper, M.D., executive vice president of Research and Development at Amgen, along with members of Amgen's clinical development team, will participate to discuss data presented at ASCO and Amgen's broader oncology portfolio of products. Live audio of the conference...

2014-05-29 08:30:49

Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys Shared with 10-City Hope Murals Project CHICAGO, May 29, 2014 /PRNewswire/ -- The American Society of Clinical Oncology's (ASCO) Annual Meeting, one of the largest gatherings in cancer prevention, diagnosis and treatment, brings together more than 25,000 oncology professionals from May 30 through June 3 to share the latest research in the fight against cancer. In recognition of National Cancer Survivor's Day on June 1,...

2014-05-28 12:30:34

Strand celebrates the largest commercial adoption of genomics in cancer care to date ROCKVILLE, Md., May 28, 2014 /PRNewswire/ -- Strand Genomics Inc. (Strand), a global leader in clinical genomics, has announced a major initiative with Health Care Global Enterprises, Ltd (HCG) to provide personalized genomics services for oncology. Strand's clinical genomics solutions for oncology offered by the Strand-Triesta Center for Cancer Genomics (Strand-Triesta) include both cancer risk...

2014-05-28 08:32:17

SAN FRANCISCO and NEW YORK, May 28, 2014 /PRNewswire/ -- MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), and CollabRx, Inc. (NASDAQ: CLRX) announced today the introduction of a new physician resource, CancerRx,(TM) an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options. http://photos.prnewswire.com/prnvar/20101112/NY00568LOGO "The introduction of CancerRx expands MedPage Today's relationship...

2014-05-27 08:29:47

Fully automated system effectively isolates and retrieves circulating tumour cells for timely, tailored treatment of cancer CHICAGO, May 27, 2014 /PRNewswire/ -- Clearbridge BioMedics will launch its ClearCell(® )FX System at the upcoming American Society of Clinical Oncology (ASCO) 2014 Annual Meeting. This is Clearbridge BioMedics' next-generation device that is able to isolate and capture circulating tumour cells (CTCs)[1] from a blood sample. This is crucial for both research...

2014-05-27 08:29:17

Clinical Pathways hit "triple aim of healthcare" by reducing total costs and improving care, without sacrificing physician reimbursement, says chief medical officer DUBLIN, Ohio, May 27, 2014 /PRNewswire/ -- A series of new clinical studies found that Cardinal Health Specialty Solutions' Clinical Pathways program sharply reduces the cost of cancer treatment, improves clinical care and shows promise for guiding treatment of other high-cost, complex diseases beyond cancer. The five...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.